PODD (STOCKS)
Insulet Corporation
$197.810000
+0.880000 (+0.45%)
Prev close: $196.930000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Ashley A. McEvoy
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13,919.37M
- Employees
- 3,900
- P/E (TTM)
- 56.60
- P/B (TTM)
- 9.15
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
13
Strong Buy
18
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.55 | $1.48 | +0.0668 | +4.50% |
|
Sep 2025 (Q3)
|
$1.24 | $1.16 | +0.0757 | +6.50% |
|
Jun 2025 (Q2)
|
$1.17 | $0.95 | +0.2242 | +23.70% |
|
Mar 2025 (Q1)
|
$1.01 | $0.81 | +0.1988 | +24.51% |
Financial Statements
| Revenues | $2.71B |
| Benefits Costs and Expenses | $2.37B |
| Cost Of Revenue | $768.20M |
| Costs And Expenses | $2.37B |
| Gross Profit | $1.94B |
| Operating Expenses | $1.47B |
| Selling, General, and Administrative Expenses | $1.17B |
| Research and Development | $301.10M |
| Operating Income/Loss | $473.80M |
| Income/Loss From Continuing Operations After Tax | $247.10M |
| Income/Loss From Continuing Operations Before Tax | $339.50M |
| Income Tax Expense/Benefit | $92.40M |
| Income Tax Expense/Benefit, Current | $30.10M |
| Income Tax Expense/Benefit, Deferred | $62.30M |
| Net Income/Loss | $247.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $247.10M |
| Net Income/Loss Available To Common Stockholders, Basic | $247.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.51 |
| Diluted Earnings Per Share | $3.48 |
| Basic Average Shares | 70,348,000 |
| Diluted Average Shares | 71,886,000 |
| Assets | $3.19B |
| Current Assets | $1.91B |
| Inventory | $452.60M |
| Other Current Assets | $1.46B |
| Noncurrent Assets | $1.28B |
| Liabilities | $1.68B |
| Current Liabilities | $680.10M |
| Accounts Payable | $75.00M |
| Other Current Liabilities | $605.10M |
| Noncurrent Liabilities | $995.10M |
| Equity | $1.52B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.52B |
| Liabilities And Equity | $3.19B |
| Net Cash Flow From Operating Activities | $569.30M |
| Net Cash Flow From Operating Activities, Continuing | $569.30M |
| Net Cash Flow From Investing Activities | -$222.70M |
| Net Cash Flow From Investing Activities, Continuing | -$222.70M |
| Net Cash Flow From Financing Activities | -$595.30M |
| Net Cash Flow From Financing Activities, Continuing | -$595.30M |
| Exchange Gains/Losses | $11.50M |
| Net Cash Flow | -$237.20M |
| Net Cash Flow, Continuing | -$248.70M |
| Comprehensive Income/Loss | $272.80M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $272.80M |
| Other Comprehensive Income/Loss | $272.80M |
| Other Comprehensive Income/Loss Attributable To Parent | $25.70M |